Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $35M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
419% more capital invested
Capital invested by funds: $6.75M → $35M (+$28.3M)
42% more funds holding
Funds holding: 19 → 27 (+8)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
96% less call options, than puts
Call options by funds: $36K | Put options by funds: $826K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
Fortress Investment Group
New York
|
+$13M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$688K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$518K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$177K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$93.8K |
| 2 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$61K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$20K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.17K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$7.38K |
CORV Hedge Fund Activity: Q4 2013 in Review
27 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2013, worth a combined $35M — up 419% from $6.75M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CORV positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Fortress Investment Group, opening a new position worth an estimated $13M. The largest seller was Deutsche Bank, cutting an estimated $93.8K.
- 27 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2013, up from 19 in Q3 2013.
- Funds reported $35M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2013, up 419% quarter-over-quarter.
- 9 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2013 and 1 closed out, a net change of +8 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2013 was Fortress Investment Group, an estimated $13M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2013 was Deutsche Bank, an estimated $93.8K sold.
Based on aggregated 13F filings for Q4 2013.